Tens of thousands of Americans will soon be forced by their heath insurance to switch from one popular obesity drug to another that produces less weight loss. It is the latest example of the consequences of secret deals between drugmakers and middlemen, known as pharmacy benefit managers, that are hired by employers to oversee prescription…
WeightWatchers, a 62-year-old health and wellness company that has faced stiff competition from new weight-loss drugs and programs, filed for bankruptcy on Tuesday in an effort to reduce its debt by more than $1 billion while it expands its telehealth business. In its heyday, WeightWatchers shaped how millions of people in the United States and…
Do we really have free will when it comes to eating? It’s a vexing question that is at the heart of why so many people find it so difficult to stick to a diet. To get answers, one neuroscientist, Harvey J. Grill of the University of Pennsylvania, turned to rats and asked what would happen…
Countless students across the globe grow up dreaming of America. Not for its skylines or celebrities. But for its classrooms. The Ivy Leagues and sprawling classrooms of American universities reverberate with a promise of intellectual freedom, imparting top-notch education. But that dream, carried by the world’s brightest minds, is getting fractured under the immense strain…
Lovlina Borgohain (Photo Credit: X) NEW DELHI: Tokyo Olympics bronze medallist Lovlina Borgohain faces a significant decision regarding her weight category for the 2028 Los Angeles Games. The International Olympic Committee (IOC) has scrapped her current 75kg weight class, forcing her to choose between moving down to 70kg or bulking up to the +80kg division.The…
The Trump administration on Friday rejected a Biden plan that would have required Medicare and Medicaid to cover obesity drugs and expanded access for millions of people. Under the law that established Medicare’s Part D drug benefits, the program was forbidden from paying for drugs for “weight loss.” The Biden administration’s proposal last November had…
Blockbuster weight loss drug Mounjaro launched, prices starts at Rs 3500 per vial NEW DELHI: Pharma major Eli Lilly on Thursday announced the launch of Mounjaro – a blockbuster weight-loss drug that is a big hit in the UK, Europe and other countries already – in India.Mounjaro, an injectable drug that aids weight loss by…
It’s easy to make a medical case for blockbuster weight loss drugs like Wegovy and Zepbound, which have been shown to prevent heart attacks and strokes and save lives. But for the employers and government programs being asked to pay for the medications, the financial case for them is less clear. Are the drugs’ benefits…
Anorexia: केरल में एक 18 साल की लड़की की खाने की बीमारी ‘एनोरेक्सिया’ से पीड़ित होने के कारण मौत हो गई. मृतका ने लगभग 6 महीने से खाना छोड़ रखा था. कन्नूर जिले के थालास्सेरी की रहने वाली नंदा को-ऑपरेटिव अस्पताल में भर्ती थी, जहां रविवार को उसकी मौत हो गई, नंदा वजन घटाने के…
Novo Nordisk will cut the price of its blockbuster weight loss medication Wegovy to $499 per month for certain patients who pay using their own money instead of going through insurance, the drug maker said on Wednesday. The move could cause more patients to start taking the drug. But the impact stands to be limited,…